30 results
424B3
PTPI
Petros Pharmaceuticals Inc
19 Sep 23
Prospectus supplement
4:36pm
, as amended (the “Sarbanes–Oxley Act”);
reduced disclosure obligations regarding executive compensation in our periodic reports, proxy statements … and registration statements; and
exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval
POS AM
rhnyu1d5 sht
14 Oct 22
Prospectus update (post-effective amendment)
4:05pm
PRE 14A
9eg636b8t4pd0
30 Sep 22
Preliminary proxy
4:45pm
424B3
pk9r1ys cd49446z
14 Jan 22
Prospectus supplement
5:18pm
424B5
nxw2gb6v
23 Dec 21
Prospectus supplement for primary offering
5:01pm
424B3
pkcpw6q
20 Dec 21
Prospectus supplement
7:24am
424B5
v2hggxgs y3d
1 Dec 21
Prospectus supplement for primary offering
5:10pm
424B3
nkcf2ddq
23 Nov 21
Prospectus supplement
4:11pm